Piper Sandler Maintains Overweight on Illumina, Raises Price Target to $305

Benzinga Newsdesk www.benzinga.com Positive 75.8%

Neg 0% Neu 0% Pos 75.8%

Piper Sandler analyst David Westenberg maintains Illumina (NASDAQ:ILMN) with a Overweight and raises the price target from $225 to $305.